CBC Innovation Breakfast: Detecting Emotional Distress Earlier Through Biology and Data
Event details
- When: 9:30 to 10:30am, Wednesday 28th January 2026
- Where: The Hub – AstraZeneca, Cambridge Biomedical Campus
Francis Crick Avenue, Trumpington, Cambridge CB2 0AA. Find The Hub on What3Words: ///things.spared.librarian - Pastries and refreshments provided
Learn more about a biochemical tool for early detection of emotional distress
Hear how two decades in health and life sciences led Rob Pegram, Founder of Neuropath, to innovate the first biochemical tool for early detection of emotional distress, which will fit within standard GP workflows. The session will explore the issue, solution, progress and next steps.
NeuroPath Biosciences is developing the world’s first biochemical diagnostic for emotional distress. By combining blood-based biomarkers with digital assessments and AI, they aim to transform early detection and prevention of self-harm in young people.
About our innovation breakfasts
Our Innovation Breakfast series brings together aspiring innovators and clinicians with expert speakers to explore what it takes to turn a great idea into something that can make a difference for patients.
From industry partners and technical specialists to those who have been successful entrepreneurs with a story to share, join us to network, learn and enjoy a pastry.
Who Should Come?
We encourage attendance from:
- Staff across our partner organisations
- Professionals focused on service improvement
- Leaders in strategy, policy, and partnerships
- Colleagues working on public and patient involvement and engagement (PPIE)
If you would like to be involved in a future Innovation Breakfast, contact comms@cuhp.org.uk.
You might also like…
You can see all upcoming events on the Cambridge Biomedical Campus on our ‘What’s on’ page…
Find out more
back